Phase
Condition
Circulation Disorders
Vascular Diseases
Dizzy/fainting Spells
Treatment
Phenylephrine
Saline Control
Clinical Study ID
Ages 18-45 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 to 45 years of age
Non-obese (Body Mass Index less than 30 kg/m2)
Baseline systolic blood pressure between 80-140 mmHg
Baseline diastolic blood pressure <90 mmHg
Exclusion
Exclusion Criteria:
Participants who have cardiac, vascular, respiratory, neurological and/or metabolicillness
Current or previous use of anti-hypertensive medications
Any known history of renal or hepatic insufficiency/disease
Pregnancy (verified by negative urine test on the experimental days) orbreast-feeding
Current smokers, as well as individuals who regularly smoked within the past 3 years
Sulfite allergy, as this is a contraindication to intravenous phenylephrine
Serious mental illness including claustrophobia
History of use of recreational drugs including cocaine or amphetamines
Peripheral vascular disease
Subject on anticoagulant treatment
Subjects with a baseline systolic blood pressure <80 mmHg
Study Design
Study Description
Connect with a study center
Texas Health Resources
Dallas, Texas 75231
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.